Tarcocimab tedromer showed positive results in improving #diabeticretinopathy in the GLOW study, achieving at least a two-step improvement in the DRSS score and reducing the risk of vision-threatening complications. bit.ly/47DY5ay#ophthamology#MedED#MedTwitter
📢 Recent research unveils unaddressed patient risks:
1️⃣ Transgender adolescent menstruation
2️⃣ Testosterone use in transgender men
3️⃣ Breast cancer screening in trans & gender diverse
Patient well-being matters! #Healthcare#TransHealth#Safetybit.ly/3CgkMFd